Deal Announcements

Accu-Break Nets Venture Capital Debt And Equity

Tuesday, May 21, 2013 5:34:00 AM PDT | VentureDeal

Plantation, Florida  --  Accu-Break Pharmaceuticals has received $1 million in new venture capital equity and debt financing, according to an SEC regulatory filing.

Accu-Break has developed partial dose tablet technologies that help address the individualized dosing needs of patients.

Investors in the financing were not disclosed, knows how the company intends to use the proceeds.

Accu-Break is still seeking $500,000 in additional financing, according to the filing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1